Is pregnancy implants the next big thing in breeding treatment?
Recently, a girl made headlines for being the first child to be born in Britain by pregnancy. While these procedures are rare and complex, they provide a new way for motherhood for women with infertility of the uterus.

There has been great progress in the field of breeding health. In addition to either adopting IVF (in vitro fertilization) or ICSI (intrastoplasmic sperm injection), low-obvious pregnancy transplantation is providing new hope to women who have an absent or a relaxed uterus.
Recently, a girl made headlines for being the first child to be born in Britain by pregnancy, whose mother, Grace Davidson underwent surgery. The mother’s sister donated her pregnancy during the 8-hour transplant surgery in 2023 and caused “amazing” medical success.
While Davidson’s surgery in the UK was funded by the UK UK, India had already withdrawn its first successful pregnancy transplant in 2017.
India’s first uterine transplant
India has also been at the forefront of uterine transplant surgery. In May 2017, the surgeon made headlines by performing the country’s first and second pregnancy implants in two consecutive days at the Galaxy Care Hospital in Pune.
The first uterine transplant in India was performed on a 21 -year -old woman who was born without pregnancy.
Doctors transplanted their mother’s uterus using minimum invasive laparoscopic techniques for most of the process, followed by a small surgical incision to complete limb transfer.
This approach reduced blood loss and ensured a smooth recovery for the donor, which passed through the hysterectomy.

Soon after, a second transplant was done on a 24 -year -old woman from Baroda. His 45 -year -old mother donated the uterus. Dr. The two donors, led by Shailesh Pantambar, were well recovered after surgery.
In October 2018, India welcomed its first baby born to a transplanted uterus, the weight of a healthy baby was 1.45 kg, which was given through the Caesarean section in the same hospital.
A study published in the Journal of the American Medical Association (JAMA) reported a one -year graft survival rate, with 58% of the recipients distribute to children living in the US.
This means that about 74% of the uterine transplants remain functional (ie, continue to survive and work properly for at least one year after the implanted uterine surgery).
In other words, about 3 of the 4 women undergoing an uterine implants have a successful process where the implanted organ is not rejected by the body, normal blood flow, and is sufficient to support menstruation and potential pregnancy.

More than half of women undergoing the process go to distribute full-term, healthy infants. Importantly, there are no congenital abnormalities in children born through this method.
A successful uterine transplant can be a great boon, the doctor agrees.
Can it deal with increasing infertility in India?
Womb transplants are rare and complex processes, with strict medical criteria for both donors and recipients.
Globally, the first successful pregnancy transplant resulted in a living birth in Sweden in 2014. India followed the suit in 2017, and the first successful birth was described after 17 months.
Advisory obstetric and gynecology at Fortis Faridabad. Isha Wadwan said, “These processes are still in the experimental phase and are not widely performed. Only some special hospitals in India, such as Galaxy Care, have tried to them.”
It is an emerging treatment for a rare type of infertility known as uterine factor infertility, affecting about 3-5% of women worldwide.
Shilpa Singhal, advisor to Birla Fertility and IVF Dwaraka, said, “These are women born without a uterus, with a distorted uterus, a severely damaged uterine lining, or those who have removed their uterus in the past, said that” Shilpa Fertility and IVF Dwarka said.

Women who want to donate to their uterus have to meet some health requirements.
They should be between 30 to 50 years old, healthy, and not thick (BMI less than 30). According to pen medicine, they should not have diabetes, HIV, hepatitis B or C, or any sexually transmitted diseases.
If they were cancer or were treated for it in the last five years, they cannot be a donor.
Uterine implants should be performed only by specially trained gynecological transplant surgeons. After surgery, the woman requires time to completely heal before trying to get pregnant, usually recommended a recovery of about six months.
In India, the process is regulated under the Notto (National Organ and Tissue Transplant Organization) Act. It is highly complex and requires both a donor and recipient to meet strict health criteria, such as a healthy BMI, no history of high blood pressure, diabetes, viral infections, drugs, smoking or prohibition.
Dr. Sinhal said, “Post-transplant, women are prescribed for at least one year and even during pregnancy to ensure optimal uterine health. The delivery post-eore transplant is usually through C-section,” Dr. Singhal said.
Who can donate and what is its cost?
The uterus donors can either live or be dead.
The living donors are often close relatives like mothers or sisters, who offer their uterus for philanthropic reasons. The process involves a complex surgical process where the donor’s uterus is carefully removed and transplanted into the recipient.

For living donors, recovery time is important as it carries specific surgical risks.
Dr. Wadhavan said, “In the case of deceased donors, the limbs are recovered according to the organ donation protocol. Proper consent and moral views are paramount, ensuring that the donors or their families fully know about the implication and risk,” Dr. The constitution said.
A uterine transplant in India costs between Rs 10 lakh and Rs 25 lakh, with surgery, hospitalized and post-operative care is covered.
Because it is still an experimental treatment, insurance coverage is limited.
what lies ahead
While successful uterine transplants and births are still rare, they provide a new way to motherhood for women with infertility of the uterus.
Both Indian and international cases suggest that with correct expertise and continuous research, this treatment can be more accessible in the future.